CGM Wearables Beyond Diabetes

Lucas and Luna explore the rise of continuous glucose monitors as everyday health wearables. They dig into how companies like Levels and Nutrisense are repurposing CGM technology for metabolic optimization in non-diabetic users. The episode centers on a February 2026 study from Stanford showing that personalized diet adjustments based on real-time glucose data improved energy stability by 22 percent in a cohort of 500 knowledge workers. They debate the cost barrier, the evidence base, and whether the mass market is ready for a sensor you wear for weeks. Specific examples include the Abbott FreeStyle Libre 3's upcoming consumer launch and the backlash over data accuracy claims. The hosts also touch on regulatory shifts at the FDA that opened the door for wellness-focused CGMs. Lucas argues the tech is a genuine breakthrough; Luna questions whether it creates unnecessary health anxiety. The show closes with a look at what a $99 CGM subscription could mean for preventive health. #ContinuousGlucoseMonitor #CGM #WearableTech #HealthTech #MetabolicHealth #LevelsHealth #Nutrisense #Abbott #FreeStyleLibre #StanfordStudy #Biowearables #PreventiveHealth #PersonalizedNutrition #BloodSugar #FDA #FexingoBusiness #BusinessPodcast #Technology Keep every episode free: buymeacoffee.com/fexingo